Crowdonomics
This isn’t CBD Life Sciences Inc.’s most recent raise. Reg A+ · Equity · May 2026 (Open) is more current.View latest round
CBD Life Sciences Inc.

Reg A+ · Equity · May 2019

ClosedReg A+Equity
via the platform · last checked Sep 24, 2026
Raised
$7.8M / $10M max
78% of ceiling
Investors
—
—
Valuation
—
—

Financials disclosed in this offering

No financial statements linked to this round

The issuer's filing for this offering hasn't been parsed into fiscal-year statements yet.

Amendments to this offering

15 amendments
  1. Jun 29, 2021
    Terms not yet extracted from this filing
    Form 1-A POS on EDGAR ↗
  2. Feb 5, 2021
    Terms not yet extracted from this filing
    Form 1-A POS on EDGAR ↗
  3. Jan 22, 2021
    Terms not yet extracted from this filing
    Form 1-A POS on EDGAR ↗
  4. Nov 17, 2020
    Terms not yet extracted from this filing
    Form 1-A POS on EDGAR ↗
  5. Nov 3, 2020
    Terms not yet extracted from this filing
    Form 1-A POS on EDGAR ↗
  6. Sep 23, 2020
    Terms not yet extracted from this filing
    Form 1-A POS on EDGAR ↗
  7. Feb 27, 2020
    Terms not yet extracted from this filing
    Form 1-A/A on EDGAR ↗
  8. Feb 25, 2020
    Terms not yet extracted from this filing
    Form 1-A/A on EDGAR ↗
  9. Feb 21, 2020
    Terms not yet extracted from this filing
    Form 1-A/A on EDGAR ↗
  10. Feb 14, 2020
    Terms not yet extracted from this filing
    Form 1-A/A on EDGAR ↗
  11. Feb 11, 2020
    Terms not yet extracted from this filing
    Form 1-A/A on EDGAR ↗
  12. Jan 15, 2020
    Terms not yet extracted from this filing
    Form 1-A/A on EDGAR ↗
  13. Oct 17, 2019
    Terms not yet extracted from this filing
    Form 1-A/A on EDGAR ↗
  14. Sep 23, 2019
    Terms not yet extracted from this filing
    Form 1-A/A on EDGAR ↗
  15. Aug 7, 2019
    Terms not yet extracted from this filing
    Form 1-A/A on EDGAR ↗

Each line compares the amendment with the previous filing of this offering. Form 1-A amendments state no reason; those filed before qualification are usually responses to SEC staff review.

Deal terms

Price / share$0.10
Price / share today$30.00
Shares offered100,000,000

$0.10 as sold; $30.00 after the Apr 2024 split (1:300) (Form 1-A, p. 1).

Offering details

Target—
Max$10,000,000
Min investment—
OpenedMay 22, 2019
Deadline—
ClosedAug 18, 2022
Days active1,184

Links & provenance

Source: SEC EDGAR
0001683168-19-001682
Last synced Sep 24, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.